180 related articles for article (PubMed ID: 25046223)
1. Differential expression of glypican-1 in ameloblastoma variants.
Bologna-Molina R; Mosqueda-Taylor A; Molina-Frechero N
Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):153-60. PubMed ID: 25046223
[TBL] [Abstract][Full Text] [Related]
2. Expression of proteoglycans in two types of ameloblastoma: novel Immunohistochemical findings.
Gómez-Herrera Z; Molina-Frechero N; Damián-Matsumura P; González-González R; Farfán-Morales JE; Bologna-Molina R
J Biol Regul Homeost Agents; 2018; 32(3):479-487. PubMed ID: 29921372
[TBL] [Abstract][Full Text] [Related]
3. [Odontogenic tumors].
Roque ML
Rev Port Estomatol Cir Maxilofac; 1982; 23(2):243-88. PubMed ID: 7188092
[No Abstract] [Full Text] [Related]
4. BRAFV600E mutation in the diagnosis of unicystic ameloblastoma.
Pereira NB; Pereira KM; Coura BP; Diniz MG; de Castro WH; Gomes CC; Gomez RS
J Oral Pathol Med; 2016 Nov; 45(10):780-785. PubMed ID: 27084044
[TBL] [Abstract][Full Text] [Related]
5. Glypican-3 distinguishes aggressive from non-aggressive odontogenic tumors: a preliminary study.
Mendes RB; Dias RB; Figueiredo AL; Gurgel CA; Santana Filho M; Melo LA; Trierveiler M; Cury PR; Leonardi R; Dos Santos JN
J Oral Pathol Med; 2017 Apr; 46(4):297-300. PubMed ID: 27647326
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD90 and P75NTR stem cell markers in ameloblastomas: a possible role in their biological behavior.
Silva FP; Dias A; Coelho CA; Guerra EN; Marques AE; Decurcio DA; Mantesso A; Cury SE; Silva BS
Braz Oral Res; 2016 Oct; 30(1):e109. PubMed ID: 27737362
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of bone remodeling molecules expression in different types of jaw ameloblastoma.
Iakovou M; Chrysomali E; Piperi E; Fanourakis G; Sklavounou A; Vlachodimitropoulos D; Tseleni-Balafouta S
J Oral Pathol Med; 2015 Aug; 44(7):543-51. PubMed ID: 25243582
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of MDM2 protein in ameloblastomas as compared to adenomatoid odontogenic tumor.
Krishna A; Kaveri H; Naveen Kumar RK; Kumaraswamy KL; Shylaja S; Murthy S
J Cancer Res Ther; 2012; 8(2):232-7. PubMed ID: 22842367
[TBL] [Abstract][Full Text] [Related]
9. Calretinin expression in the differential diagnosis of human ameloblastoma and keratocystic odontogenic tumor.
DeVilliers P; Liu H; Suggs C; Simmons D; Daly B; Zhang S; Raubenheimer E; Larsson A; Wright T
Am J Surg Pathol; 2008 Feb; 32(2):256-60. PubMed ID: 18223328
[TBL] [Abstract][Full Text] [Related]
10. Expression of midkine in ameloblastomas and its correlation with clinicopathologic parameters.
Scheper MA; Duarte EC; Intapa C; Zhang M; Nascimento LM; Almeida TP; Gomes AC; Song S; Chaisuparat R; Batista AC; Jham BC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Oct; 114(4):497-502. PubMed ID: 22986245
[TBL] [Abstract][Full Text] [Related]
11. Expression of extracellular matrix proteins in ameloblastomas and adenomatoid odontogenic tumors.
de Medeiros AM; Nonaka CF; Galvão HC; de Souza LB; Freitas Rde A
Eur Arch Otorhinolaryngol; 2010 Feb; 267(2):303-10. PubMed ID: 19466441
[TBL] [Abstract][Full Text] [Related]
12. Intraosseous ameloblastoma.
Black CC; Addante RR; Mohila CA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Nov; 110(5):585-92. PubMed ID: 20580278
[TBL] [Abstract][Full Text] [Related]
13. Expression of Twist in different subtype of ameloblastomas.
Feng Y; Zhou YM; Hua CG; Tang XF; He DQ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Oct; 108(4):565-70. PubMed ID: 19699120
[TBL] [Abstract][Full Text] [Related]
14. Odontogenic tumors: analysis of 706 cases.
Regezi JA; Kerr DA; Courtney RM
J Oral Surg; 1978 Oct; 36(10):771-8. PubMed ID: 280645
[TBL] [Abstract][Full Text] [Related]
15. Ameloblastoma and adenomatoid odontogenic tumor: the role of alpha2beta1, alpha3beta1, and alpha5beta1 integrins in local invasiveness and architectural characteristics.
Souza Andrade ES; da Costa Miguel MC; Pinto LP; de Souza LB
Ann Diagn Pathol; 2007 Jun; 11(3):199-205. PubMed ID: 17498594
[TBL] [Abstract][Full Text] [Related]
16. [Ameloblastomas in the growth period--aspects of differential diagnosis and therapy].
Ehrenfeld M; Donath K; Riediger D; Mast G; Gärtner HV
Dtsch Zahnarztl Z; 1991 Jan; 46(1):77-9. PubMed ID: 1811982
[TBL] [Abstract][Full Text] [Related]
17. Comparative expression of RANK, RANKL, and OPG in keratocystic odontogenic tumors, ameloblastomas, and dentigerous cysts.
da Silva TA; Batista AC; Mendonça EF; Leles CR; Fukada S; Cunha FQ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Mar; 105(3):333-41. PubMed ID: 18061491
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of Ki-67 and Glypican-3 to distinguish aggressive from nonaggressive benign odontogenic tumors.
Chaturvedi TP; Gupta K; Agrawal R; Naveen Kumar PG; Gupta J
J Cancer Res Ther; 2022 Dec; 18(Supplement):S205-S209. PubMed ID: 36510965
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical Expression of GLUT-1 and HIF-1α in Tooth Germ, Ameloblastoma, and Ameloblastic Carcinoma.
Sánchez-Romero C; Bologna-Molina R; Mosqueda-Taylor A; Paes de Almeida O
Int J Surg Pathol; 2016 Aug; 24(5):410-8. PubMed ID: 27020375
[TBL] [Abstract][Full Text] [Related]
20. CD10 expression in stromal cells of ameloblastoma variants.
Iezzi G; Piattelli A; Rubini C; Artese L; Goteri G; Fioroni M; Carinci F
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Feb; 105(2):206-9. PubMed ID: 17942343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]